financetom
Business
financetom
/
Business
/
Toast Insider Sold Shares Worth $280,766, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Toast Insider Sold Shares Worth $280,766, According to a Recent SEC Filing
Jul 7, 2025 1:59 PM

04:42 PM EDT, 07/07/2025 (MT Newswires) -- Jonathan Vassil, Chief Revenue Officer, on July 02, 2025, sold 6,592 shares in Toast (TOST) for $280,766. Following the Form 4 filing with the SEC, Vassil has control over a total of 61,791 Class A common shares of the company, with 61,791 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1650164/000165016425000260/xslF345X05/wk-form4_1751920396.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Premarket Decliners
Top Premarket Decliners
Nov 11, 2024
07:49 AM EST, 11/11/2024 (MT Newswires) -- Dogwood Therapeutics ( DWTX ) shares slumped nearly 30% pre-bell Monday following a 2.3% loss in the previous session. Sapiens (SPNS) shares retreated 21% after the company reported Q3 revenue that trailed analysts' estimates. Monday.com ( MNDY ) shares fell 14% following a 1.8% gain in the previous session. Vision Marine Technologies (...
First Watch Restaurant to Acquire 16 Franchise Restaurants in Carolinas
First Watch Restaurant to Acquire 16 Franchise Restaurants in Carolinas
Nov 11, 2024
07:46 AM EST, 11/11/2024 (MT Newswires) -- First Watch Restaurant Group ( FWRG ) said Monday it has agreed to buy 15 of its franchise-owned restaurants, one under-construction restaurant, and corresponding development rights for $49 million in Carolinas. The company intends to finance the acquisition, expected to be completed by mid-April next year, through cash and available borrowings under its...
Unicycive Therapeutics Says FDA Accepts New Drug Application for Oxylanthanum Carbonate
Unicycive Therapeutics Says FDA Accepts New Drug Application for Oxylanthanum Carbonate
Nov 11, 2024
07:47 AM EST, 11/11/2024 (MT Newswires) -- Unicycive Therapeutics ( UNCY ) said Monday that the US Food and Drug Administration has accepted its new drug application for oxylanthanum carbonate, and has set a target action date set of June 28, 2025. The drug is a potential treatment for hyperphosphatemia in patients with chronic kidney disease on dialysis, the company...
NuCana Reports 'Encouraging' Data From Study to Treat Patients With Lung Cancer
NuCana Reports 'Encouraging' Data From Study to Treat Patients With Lung Cancer
Nov 11, 2024
07:48 AM EST, 11/11/2024 (MT Newswires) -- NuCana ( NCNA ) said Monday that initial data from an ongoing Phase 1b/2 study of NUC-3373 in combination with pembrolizumab indicated a significant reduction in tumor volume in patients with lung cancer. NUC-3373 may be an attractive alternative to pemetrexed in patients with NSCLC and mesothelioma, David Harrison, NuCana's ( NCNA )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved